MARKET

BXPHF

BXPHF

Botanix Pharma
OTCPK
0.043
-0.000
-0.47%
Closed 09:50 03/13 EDT
OPEN
0.043
PREV CLOSE
0.043
HIGH
0.043
LOW
0.043
VOLUME
5.00K
TURNOVER
214
52 WEEK HIGH
0.230
52 WEEK LOW
0.043
MARKET CAP
94.93M
P/E (TTM)
-1.3806
1D
5D
1M
3M
1Y
5Y
1D
Botanix to Lift Voluntary Escrow on 3.1 Million Shares
TipRanks · 2d ago
Botanix Revises Securities Purchase Plan Timetable and Sets Approval Date
TipRanks · 4d ago
Botanix updates timetable for share purchase plan securities issue
TipRanks · 4d ago
Botanix Opens Underwritten Security Purchase Plan to Fund Dermatology Growth
TipRanks · 4d ago
Botanix launches underwritten SPP and option offers tied to shareholder approval
TipRanks · 4d ago
Botanix Pharmaceuticals price target lowered to A$1 from A$2 at H.C. Wainwright
TipRanks · 03/04 11:12
Botanix Pharmaceuticals’ Sofdra Drives Growth Amid Cash Strain
TipRanks · 03/04 00:10
Botanix outlines limits and risks in 2026 half-year investor briefing
TipRanks · 03/02 23:36
More
About BXPHF
Botanix Pharmaceuticals Limited is an Australia-based dermatology company. The Company’s lead product is Sofdra (sofpironium) topical gel, 12.45%, a prescription anticholinergic medicine used on the skin (topical), to treat excessive underarm sweating (primary axillary hyperhidrosis) in adults and children nine years of age and older. Sofdra regulates sweating at the site of application, by binding to the primary sweat receptor and thereby blocking the sweat signal. Its product pipeline targets the various skin diseases, such as BTX 1503 for Acne, BTX 1702 for Rosacea, BTX 1204A for Atopic Dermatitis, and BTX 1801 for Hemodialysis Patients. Its BTX 1503 is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. BTX 1702 is used for the treatment of papulopustular rosacea. BTX 1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus (MRSA).

Webull offers Botanix Pharmaceuticals Ltd stock information, including OTCPK: BXPHF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BXPHF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BXPHF stock methods without spending real money on the virtual paper trading platform.